Media Contact:
Simone Hoffmann & Kerstin Mahle
E-Mail: marketing@de.gbo.com
Innovative surface leading to considerably higher cell yields
Frickenhausen, October 2008 – For the first time at Biotechnica 2008, Greiner Bio-One is presenting Advanced TC™ cell culture products with an innovative polymer modification. The special surface of the new product range optimises cultivation of fastidious cells and facilitates complex experimental approaches.
Stratec, Greiner Bio-One and Maven announce development co-operation for label free system solution
Birkenfeld July 28th, 2008 - Stratec Biomedical Systems AG, Birkenfeld, Germany, Greiner Bio-One GmbH, Frickenhausen, Germany and Maven Biotechnologies, Pasadena, CA, USA signed a first agreement regarding a joint development programme.
Strategic Cooperation between European ScreeningPort GmbH and Greiner Bio-One GmbH
European ScreeningPort, the European Centre for Drug Discovery, and Greiner Bio-One GmbH,
a leading international technology partner for the diagnostic and pharmaceutical industry, are
cooperating to optimise the screening process at ESP’s facility in Hamburg, Germany.
Large working volume – low dead volume: The new 384 Deep Well Small Volume™ Microplate
Frickenhausen, 06.02.2008 – Greiner Bio-One, internationally leading technology partner for the diagnostics and pharmaceutical industry, together with Boehringer Ingelheim, Biberach, has developed the 384 Deep Well Small Volume™ Microplate for reduced volume losses during sample storage and active substance tests.
Microplates with non-binding surfaces
Frickenhausen – Greiner Bio-One announced at Medica 2007 novel microplates with
an exceptionally high protein-repellent surface. The microplates developed at the
company optimise biochemical active substance screening in that the influence of the
plate surface on the test result is minimised.
Greiner Bio-One GmbH and CellMade S.A.S. agree on the joint development of cell biological products
Frickenhausen, 01/10/2007 – Greiner Bio-One GmbH, internationally leading technology partners to the diagnostic and pharmaceutical industry, and the French company CellMade are jointly publishing a new catalogue for products and solutions from the field of cell based research.
Invitrogen and Greiner Bio-One Team to Increase HPV Test Reliability
Carlsbad, Calif and Frickenhausen, Germany, June 25, 2007 – Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for disease research and drug discovery, and Greiner Bio-One, an internationally leading technology partner for the diagnostics and pharmaceutical industry, have finalized a licensing agreement to help improve the reliability of Greiner Bio-One’s HPV-DNA-test PapilloCheck® and DNA-array CytoCheck® products. The agreement covers the rights for the use of dUTP (deoxyuridine triphosphate) in PCR-based (polymerase chain reaction) methods to prevent sample contamination by amplification products in aerosols.
ThinCert™Plate optimises tissue reconstruction - The ThinCert™Plate is optimised for use with air-lift cultures and holds a substantially greater volume of cell culture medium than previous cell culture plates
Archive